The party's over

That much is apparent, but what isn't clear is what the future holds for the buy side, especially when it comes to implementing technology to automate the trading and processing of OTC derivatives. By Jos Stoop

As a number of the world's largest financial institutions take their first steps down the nationalisation path, the consensus among market participants is clear: mandatory regulation of the industry is imminent with greater levels of scrutiny being brought to bear on how firms (including

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here:

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: